转型谋“聚变”,广药集团进军核药赛道

羊城派
Sep 24

近日,广药集团旗下新设立的合资子公司——白云山稀核健康医药有限公司(以下简称白云山稀核健康)技术团队在哈尔滨医科大学附属第四医院利用自主研发的先进国产固体靶系统,成功实现了锆-89的高质量制备,填补了国内空白。目前,该固体靶系统还具备镓-68、铜-64、钪-44等多种核素的生产能力,为后续研发奠定了坚实基础。天眼查显示,白云山稀核健康成立于8月15日,企业注册资本5000万元,由广药集团同厦门稀土...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10